Bumper Offer - Urjas oil Just @ Rs. 1
Sporidex 250 Capsule (10) is a prescription medicine that is available as a Capsule. Bacterial Infections are some of its major therapeutic uses. Sporidex 250 Capsule (10) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Sporidex 250 Capsule (10). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Sporidex 250 Capsule (10) are Nausea or vomiting, Allergic reaction, Rash. Apart from the aforementioned side effects, Sporidex 250 Capsule (10) can also lead to other problems, which have been listed below. These side effects of Sporidex 250 Capsule (10) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Sporidex 250 Capsule (10)'s effect is Safe during pregnancy and Safe for lactating mothers. Warnings related to Sporidex 250 Capsule (10)'s effects on the liver, heart and kidney, if any, have been listed below.
The section on Sporidex 250 Capsule (10) contraindications lists all such conditions.
Drug reaction of Sporidex 250 Capsule (10) with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Sporidex 250 Capsule (10), it is important to know that it is safe while driving, and is habit-forming.
Sporidex 250 Capsule (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Sporidex 250 Capsule (10) is used -
Severe
Moderate
Mild
Common
Is the use of Sporidex 250 Capsule (10) safe for pregnant women?
There are no side effects of Sporidex in pregnant women.
Is the use of Sporidex 250 Capsule (10) safe during breastfeeding?
Sporidex does not show any side effects in breastfeeding women.
What is the effect of Sporidex 250 Capsule (10) on the Kidneys?
Sporidex may have mild side effects on the kidneys.
What is the effect of Sporidex 250 Capsule (10) on the Liver?
Using Sporidex does not have any harmful effects on the liver.
What is the effect of Sporidex 250 Capsule (10) on the Heart?
You can take Sporidex without any fear of damage to the heart.
Sporidex 250 Capsule (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Sporidex 250 Capsule (10) unless your doctor advises you to do so -
Is this Sporidex 250 Capsule (10) habit forming or addictive?
Forming a habit of Sporidex 250 Capsule (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Sporidex 250 Capsule (10) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sporidex 250 Capsule (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sporidex 250 Capsule (10) for mental disorders.
Interaction between Food and Sporidex 250 Capsule (10)
Taking Sporidex 250 Capsule (10) with food does not cause any problems.
Interaction between Alcohol and Sporidex 250 Capsule (10)
It is difficult to say anything about the effect of Sporidex 250 Capsule (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
